SMARCB1 and colorectal carcinoma: Furthermore, SMARCB1 KD enhanced the ability of pro-differentiation drug all-trans retinoic acid (ATRA)35,36 to induce KRT20 expression in human CRC (Supplementary Fig. 4e).